NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,334,000 | -45.5% | 703,375 | -25.7% | 0.03% | -44.8% |
| Q1 2019 | $6,120,000 | +34.8% | 947,295 | +4.9% | 0.06% | +20.8% |
| Q4 2018 | $4,541,000 | +31.4% | 902,861 | +123.0% | 0.05% | +65.5% |
| Q3 2018 | $3,457,000 | -31.8% | 404,850 | +0.7% | 0.03% | -38.3% |
| Q2 2018 | $5,068,000 | – | 402,210 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $25,718,000 | 7.00% |
| HARVARD MANAGEMENT CO INC | 505,871 | $1,335,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,050,000 | $2,772,000 | 0.17% |
| Maven Securities LTD | 381,150 | $1,006,000 | 0.12% |
| Athanor Capital, LP | 547,651 | $1,446,000 | 0.09% |
| MONETA GROUP INVESTMENT ADVISORS LLC | 102,652 | $271,000 | 0.03% |
| TERRIL BROTHERS, INC. | 19,300 | $51,000 | 0.02% |
| MEEDER ASSET MANAGEMENT INC | 5,878 | $15,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 94,908 | $251,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |